Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
ConocoPhillips enters the final stretch before its November 5 earnings with analysts raising targets, short sellers continuing to exit, and the stock up 3% on the week, a tighter, cleaner setup than the one described in last week's note.
The most notable development this week is on the Street. Jefferies raised its target on COP to $174, up from $159, while maintaining a Buy rating. Truist Securities also lifted its target, moving to $136 from $130, though it holds a Hold. Both actions came on October 7, the same day. UBS had already moved in September, pushing its Buy target to $169 from $153. The direction of travel is clear: analysts who were already positive are becoming more so. The mean target across the coverage universe is $146.88, against a current price of $129.35. That gap of roughly 14% is the bull case in compact form. Morgan Stanley and Barclays both carry Overweight ratings, though Barclays trimmed its target modestly in August. The bear case, as articulated by Seaport Global's neutral initiation in early September, centres on commodity price volatility, interest rate sensitivity, and M&A execution risk. Bulls point to peer-leading free cash flow and limited Middle East exposure.
Short positioning has continued the retreat documented last week, but at a slower pace. Short interest as a percentage of free float is now 1.18%, down 7.5% over the past week and 4.3% over the past month. The absolute share count has fallen to roughly 14.6 million from above 18 million in mid-September. That earlier unwinding was the main story; what remains now is a low and gently declining base. Cost to borrow is 0.35%, down 14% on the week, and availability is essentially uncapped. There is no meaningful borrow squeeze pressure, and nothing in the lending market suggests fresh short conviction is building. Options positioning is similarly relaxed: the put/call ratio of 0.73 is fractionally below its 20-day average of 0.75, and the z-score of -0.64 puts it well within normal range. Neither the options nor the borrow market is flashing caution.
Retail attention remains elevated. The ORTEX alt data layer shows Wikipedia page views running at a z-score of 2.5 above the 90-day average as of late September. That is attention, not a revenue signal, and no alt data dataset for COP has been measured to lead its reported figures. The next print lands in 29 days, on November 5. The most recent earnings history shows the stock rose 2.2% the day after the August 2026 report and extended that to 8.2% over the following five sessions. The prior quarter's release produced a 2.1% day-one gain but gave back ground over the week, ending down 1.1%.
Institutional flows show BlackRock adding 2.7 million shares in its most recent reported period, bringing its stake to 7.8% of shares outstanding. Charles Schwab Investment Management added 3.6 million shares, and JP Morgan Asset Management added 2.3 million. The top five holders collectively control roughly 27% of the company. No Schedule 13D activist filing is on record. All disclosed 13D/G positions are passive, and stakes are as last disclosed around the 5% threshold.
With the short unwind largely complete, the conversation around COP now shifts to what the November 5 print will show and whether analyst target upgrades reflect realistic commodity assumptions. The distance between the current price and the average analyst target, and the continuing divergence between COP's year-to-date performance and that of close peers like OXY (up 6.2% on the week) and PR (up 5.4%), are the numbers to track into results day.
See the live data behind this article on ORTEX.
Open COP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
